You have no items in your shopping cart.

HIV Elisa 1+2 Ab 96T pack

HIV is an in-vitro qualitative enzyme immunoassay for the detection of antibodies to HIV-1 and /or HIV-2 in human serum or plasma. It is intended for screening of blood donors or other individuals at risk for HIV-1 and HIV-2 infection and for clinical diagnostic testing.
₹2,000.00
₹3,500.00
Manufacturer: Athenese DX
Free shipping
Delivery date 4-7 days

HIV Elisa 1+2Ab 96T pack

HIV ELISA INTENDED USE

HIV is an in-vitro qualitative enzyme immunoassay for the detection of antibodies to HIV-1 and /or HIV-2 in human serum or plasma. It is intended for screening of blood donors or other individuals at risk for HIV-1 and HIV-2 infection and for clinical diagnostic testing.

 

SALIENT FEATURES

Based on double Ag-Sandwich immunoassay technique to ensure high specificity
Solid microwells pre-coated with recombinant HIV-1 and HIV-2 Ag
Liquid conjugates composed of recombinant HIV-1 and HIV-2 Ag conjugated with HRP
Relative sensitivity: 100% and specificity: 99.9 %
Comparable accuracy to the leading other ELISA kits
Clear borderlines with high accuracy positive and negative controls
Breakaway microwell strips
Evaluated by NIB
Assay time: 90 Minutes
12-months shelf life at 2-8 °C

ORDERING INFORMATION

PRODUCT NAMEPACK SIZECATALOG NO.
HIV 96 Tests IR132096

Kit Components:

Microwells coated with HIV-1 & HIV-2 antigen
HIV Ab positive control
HIV Ab negative control
Sample diluent
HIV 1+2 HRP conjugates
Wash buffer (30 x concentrate)
TMB substrate A
TMB substrate B
Stop solution
ELISA Working Sheet
Product insert


EVALUATIONS

  • WHO EVALUATION:As per evaluation report dated 20th February, 1998 of WHO Collaborating Centre, Institutvoor Tropische Geneeskunde Nationalestraat 155-B 2000 Antwerpen, Belgium. Seven HIV-O sera were used in the reference panel all of which were tested positive by Microlisa-HIV. Microlisa-HIV was also tested on low performance and mixed panel from Boston Biomedica Inc. and the obtained results were found identical with Western Blot provided by BBI for the above panel. The specificity and sensitivity in this evaluation was found to be 100% on world wide panel.
  • Evaluation Reports of National HIV Reference Laboratories of Government of India (CMC Vellore), Drug Controller General (India), Directorate General of Health Services, Government of India, New Delhi (Letter dated 08 May, 1997). The Sensitivity and Specificity were found to be 100 % and 99.5%.
  • Indian Journal of Medical Microbiology claims 100 % Sensitivity and 100% Specificity of MICROLISA HIV.
  • NICD-DELHI-As per evaluation at National Institute of Communicable Diseases (DGHS) with 265 known samples the overall Sensitivity & Specificity was 100 % & 99.23 %.
  • Department of Microbiology, Nizam's Institute of Medical Sciences claimed the Sensitivity, Specificity and Efficiency to be 100%.
  • Approved by Drug Controller General of India (DCGI) for the usage in Blood Banks.

 

Write your own review
*
*
  • Bad
  • Excellent
*
*
*
*

HIV Elisa 1+2Ab 96T pack

HIV ELISA INTENDED USE

HIV is an in-vitro qualitative enzyme immunoassay for the detection of antibodies to HIV-1 and /or HIV-2 in human serum or plasma. It is intended for screening of blood donors or other individuals at risk for HIV-1 and HIV-2 infection and for clinical diagnostic testing.

 

SALIENT FEATURES

Based on double Ag-Sandwich immunoassay technique to ensure high specificity
Solid microwells pre-coated with recombinant HIV-1 and HIV-2 Ag
Liquid conjugates composed of recombinant HIV-1 and HIV-2 Ag conjugated with HRP
Relative sensitivity: 100% and specificity: 99.9 %
Comparable accuracy to the leading other ELISA kits
Clear borderlines with high accuracy positive and negative controls
Breakaway microwell strips
Evaluated by NIB
Assay time: 90 Minutes
12-months shelf life at 2-8 °C

ORDERING INFORMATION

PRODUCT NAMEPACK SIZECATALOG NO.
HIV 96 Tests IR132096

Kit Components:

Microwells coated with HIV-1 & HIV-2 antigen
HIV Ab positive control
HIV Ab negative control
Sample diluent
HIV 1+2 HRP conjugates
Wash buffer (30 x concentrate)
TMB substrate A
TMB substrate B
Stop solution
ELISA Working Sheet
Product insert


EVALUATIONS

  • WHO EVALUATION:As per evaluation report dated 20th February, 1998 of WHO Collaborating Centre, Institutvoor Tropische Geneeskunde Nationalestraat 155-B 2000 Antwerpen, Belgium. Seven HIV-O sera were used in the reference panel all of which were tested positive by Microlisa-HIV. Microlisa-HIV was also tested on low performance and mixed panel from Boston Biomedica Inc. and the obtained results were found identical with Western Blot provided by BBI for the above panel. The specificity and sensitivity in this evaluation was found to be 100% on world wide panel.
  • Evaluation Reports of National HIV Reference Laboratories of Government of India (CMC Vellore), Drug Controller General (India), Directorate General of Health Services, Government of India, New Delhi (Letter dated 08 May, 1997). The Sensitivity and Specificity were found to be 100 % and 99.5%.
  • Indian Journal of Medical Microbiology claims 100 % Sensitivity and 100% Specificity of MICROLISA HIV.
  • NICD-DELHI-As per evaluation at National Institute of Communicable Diseases (DGHS) with 265 known samples the overall Sensitivity & Specificity was 100 % & 99.23 %.
  • Department of Microbiology, Nizam's Institute of Medical Sciences claimed the Sensitivity, Specificity and Efficiency to be 100%.
  • Approved by Drug Controller General of India (DCGI) for the usage in Blood Banks.

 

Close